전 세계 유도만능줄기세포(iPSC) 시장 규모는 2023년 34억 달러에서 예측 기간 동안 9.1%의 연평균 복합 성장률(CAGR)을 나타내고, 2028년 말에는 52억 달러 규모로 성장할 것으로 예상됩니다.
비통합법 부문은 2023년 21억 달러에서 2028년 34억 달러에 이르고, 연평균 10.1% 성장할 것으로 예상됩니다. 통합법 부문은 2023년 13억 달러에서 2028년 18억 달러에 이르고, 연평균 7.5% 성장할 것으로 예상됩니다.
세계의 유도만능줄기세포(iPSC) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 임상시험 및 특허 동향, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
유도만능줄기세포(iPSC) 생성
제3장 시장 역학
세계 시장 역학
시장 성장 촉진요인
만성질환 증가
바이오테크놀러지 산업에 대한 투자 증가
맞춤형 의료 수요 증가
의약품 연구개발에 대한 투자 증가
효과적인 의약품 발견과 개발 프로세스에 수요
동물 실험 최소화
시장 성장 억제요인
비싼 개발비와 숙련 노동력 부족
iPSC 기반 질환 모델, 세포치료, Drug Discovery에 관련된 과제
시장 기회
기술 진보
iPSC 뱅킹 성장
제4장 신기술과 개발
iPSC 연구 진보
리프로그래밍 기술
유전자 편집 기술
3D 오가노이드
재생의료
iPSC 연구 분야의 AI 진화와 현재 응용
제5장 임상시험 분석
임상시험
제6장 특허 분석
특허 분석
제7장 시장 세분화 분석
세분화 내역
개요
iPSC 생성 : 리프로그래밍 방법별 시장 분석
iPSC 시장 : 생성법 별
iPSC 시장 : 용도별
학술 연구
약리 독성 스크리닝
Drug Discovery & Development
질환 모델링
조직공학
세포치료
세계 시장
iPSC 지역 시장 : 용도별
iPSC 유래 조직 세포 시장 : 유형별
심근세포
신경세포
내피세포
간세포
기타 세포
iPSC 유래 조직 세포 시장 : 유형별
세계 시장
iPSC 유래 조직 세포 시장 : 용도별
세계 시장
iPSC 시장 : 제품 기능별
세계 시장
iPSC 지역 시장 : 제품 기능별
iPSC 시장 : 최종사용자별
iPSC 수탁 서비스 유형
주요 기업
세계 시장
지역별 분석
iPSC 시장 : 지역별
미국
유럽
아시아태평양
기타 지역
제8장 경쟁 정보
경쟁 구도 : 개요
전략 분석
합의
협업 및 전략적 제휴
파트너십
신제품 개발·발매
확장 및 인수
자금조달
승인 및 임상시험
기타
주요 기업 : 제품 유형별
제9장 부록
조사 방법
약어
출전
기업 개요
ATCC
AXOL BIOSCIENCE LTD.
BIO-TECHNE
FUJIFILM CELLULAR DYNAMICS INC.
LONZA
MERCK KGAA
NCARDIA
QIAGEN
REPROCELL INC.
STEMCELL TECHNOLOGIES
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.
LSH
영문 목차
영문목차
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
The global market for iPSCs generated by non-integrated method is expected to grow from $2.1 billion in 2023 to reach $3.4 billion by 2028, at a CAGR of 10.1% from 2023 to 2028.
The global market for iPSCs generated by integrated method is expected to grow from $1.3 billion in 2023 to reach $1.8 billion by 2028, at a CAGR of 7.5% from 2023 to 2028.
Report Scope
The scope of this study encompasses an investigation of the market. BCC Research analyzes this market based on application type, product function, generation of iPSC and types of iPSC derived cells and species. Application-based market segments include drug development and toxicity testing, academic research and regenerative medicine. Product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis. iPSC-derived cell-type-based market segments include hepatocytes, neurons, cardiomyocytes, endothelial cells and other cell types. Other cell types include astrocytes, fibroblasts and hematopoietic progenitor cells. BCC Research determines the current market status in each segment, examines its impact on future needs and presents growth forecasts through 2028.
The report also provides a detailed analysis of the market's drivers, restraints, challenges and opportunities. In addition, the report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. it also provides detailed information on this market, emerging technologies and new developments, regulatory landscape, patent analysis, pipeline analysis and investment outlook and deals.
Report Includes
28 data tables and 56 additional tables
An analysis of the global market for induced pluripotent stem cells (iPSCs) or artificial stem cells
Analyses of global market trends, with market revenue data from 2020 to 2023, and projected CAGRs through 2028
Estimate of the size and revenue prospects of the global market, along with a market share analysis by reprogramming method, generation method, application, product function, iPSC-derived cell type, species, end use, and region
Facts and figures pertaining to the market dynamics, technological advances, regulations, and the macroeconomic factors that influence the industry
A Porter's Five Forces model, as well as global supply chain and PESTLE analyses
Insights into iPSC research activity, emerging technologies, clinical trials and pipeline products
Patent activity and analysis of recent patent grants/publications
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
Profiles of market leaders, including Fujifilm Cellular Dynamics (FCDI) Inc., Axol Bioscience Ltd., Merck KGaA, Thermo Fisher Scientific Inc., and Takara Bio Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Induced Pluripotent Stem Cells (iPSC) Generation
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Increasing Prevalence of Chronic Diseases
Increasing Investment in Biotechnology Industry
Increasing Demand for Personalized Medicines
Increasing Investments for Drug Research and Development
Demand for Effective Drug Discovery and Development Process
Minimizing Animal Testing
Market Restraints
High Development Costs and Lack of Skilled Workforce
Challenges Associated with iPSC-based Disease Modeling, Cell Therapy and Drug Discovery
Market Opportunities
Technological Advances
Growth in iPSC Banking
Chapter 4 Emerging Technologies and Developments
Advances in the iPSC Research
Reprogramming Technologies
Gene Editing Technologies
3D Organoids
Regenerative Medicine
Evolution and Current Application of Artificial Intelligence (AI) in iPSC Research
Chapter 5 Clinical Trial Analysis
Clinical Trials
Chapter 6 Patent Analysis
Patent Analysis
Chapter 7 Market Segmentation Analysis
Segmentation Breakdown
Overview
Generation of Induced Pluripotent Stem Cells -- Market Analysis, by Reprogramming Method
Market for Induced Pluripotent Stem Cells, by Generation Method
Market for Induced Pluripotent Stem Cells, by Application
Academic Research
Pharmaco-toxicological Screening
Drug Discovery and Development
Disease Modeling
Tissue Engineering
Cell Therapy
Global Market
Regional Markets for iPSCs, by Application
iPSC-derived Tissue Cell Market, by Type
Cardiomyocytes
Neurons
Endothelial Cells
Hepatocytes
Other Cells
iPSC-derived Tissue Cell Market, by Species
Global Market
iPSC-derived Tissue Cell Market, by Application
Global Market
Market for Induced Pluripotent Stem Cells, by Product Function
Global Market
Regional Markets for iPSCs, by Product Function
Market for Induced Pluripotent Stem Cells, by End Use
Induced Pluripotent Stem Cell Contract Service Types
Major Players
Global Market
Geographic Breakdown
Market for Induced Pluripotent Stem Cells, by Region
The U.S.
Europe
Asia-Pacific
Rest of the World
Chapter 8 Competitive Intelligence
Competitive Landscape -- Overview
Strategic Analysis
Agreements
Collaborations & Strategic Alliances
Partnerships
New Product Development and Launches
Expansions and Acquisitions
Fund Raising
Approval and Clinical Trials
Others
Major Companies in Induced Pluripotent Stem Cells Market, by Type of Offerings
